Thomas Okarma's Net Worth
$4.34 Million
Who is Thomas Okarma?
Thomas Okarma has an estimated net worth of $4.34 Million. This is based on reported shares across multiple companies, which include GERON CORPORATION, and Asterias Biotherapeutics, Inc..
SEC CIK
Thomas Okarma's CIK is 0001187039
Past Insider Trading and Trends
2007 was Thomas Okarma's most active year for acquiring shares with 7 total transactions. Thomas Okarma's most active month to acquire stocks was the month of April. 2009 was Thomas Okarma's most active year for disposing of shares, totalling 3 transactions. Thomas Okarma's most active month to dispose stocks was the month of December. 2009 saw Thomas Okarma paying a total of $2,836,200.00 for 545,000 shares, this is the most they've acquired in one year. In 2009 Thomas Okarma cashed out on 65,009 shares for a total of $413,332.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GERON CORP (GERN) Snapshot price: $4.29
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +77.22% | 337.5K |
—
|
—
| 774.56K |
Jul 9
| |||
Form 4
| -4.14% | -18.87K |
$5.43 | -$102,485.82 | 437.06K |
Jun 2
| |||
Form 4
| -1.01% | -4.67K |
$5.11 | -$23,868.81 | 455.93K |
May 24
| |||
Form 4
| +12.18% | 50K |
—
|
—
| 460.61K |
May 19
| |||
Form 4
| +34.00% | 104.17K |
$6.35 | -$37,007.80 | 410.61K |
May 29
| |||
Form 4
| -13.22% | -46.67K |
$6.75 | -$315,015.75 | 306.43K |
May 26
| |||
Form 4
| -3.42% | -12.51K |
$4.90 | -$61,308.80 | 353.1K |
Jan 5
| |||
Form 4
| +1.14% | 4.12K |
$3.92 | -$179,841.76 | 365.61K |
May 23 - May 28
| |||
Form 4
| -3.51% | -13.17K |
$5.34 | -$70,306.44 | 361.49K |
Jan 4
| |||
Form 4/A
| +302.90% | 281.67K |
—
|
—
| 374.66K |
May 23
| |||
Form 4
| +314.55% | 292.5K |
—
|
—
| 385.49K |
May 23
| |||
Form 4
| +194.51% | 61.42K |
—
|
—
| 92.99K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +68.26% | 12.81K |
$8.56 | -$105,459.20 | 31.57K |
Jan 6 - Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +351.32% | 14.61K |
$8.57 | -$122,405.31 | 18.77K |
Jan 12 - Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
∞
| 4.16K |
—
|
—
| 4.16K |
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Asterias Biotherapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |